Skip to main content
. 2011 Aug 7;79(4):705–727. doi: 10.3797/scipharm.1105-09

Tab. 12.

Marketed, lipid-based oral solutions.

Marketed formulation Active molecule Dosage form Manufacturer Country of sale
Agenerase® Amprenavir Oral solution GlaxoSmithKline USA
Sustiva® Efavirenz Oral solution Bristol-Myers Squibb Company USA
Rocaltrol® Calcitriol Oral solution Roche Laboratories Inc. USA